IONIS PHARMACEUTICALS INC ($IONS)
Filing Information
| Accession Number | 0000874015-26-000063 |
|---|---|
| Form Type | 4 |
| Filing Date | Jan 21, 2026 |
| Document Date | Jan 15, 2026 |
| Document | View SEC Filing |
Transactions
5
Total Shares
84,133
Total Value
$636,932.80
P&L
+inf% (+$2,518,370.25)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
EVP, Corp and Development Ops | Common Stock | โ | Jan 15, 2026 | Exercise/Conversion | 20,089 | $0.00 | $0.00 | 68,915 | Direct | โ | View Details | |
EVP, Corp and Development Ops | Common Stock | โ | Jan 16, 2026 | Sale | 8,480 | $75.11 | $636,932.80 | 60,435 | Direct | โ | View Details | |
EVP, Corp and Development Ops | Performance Restricted Stock Units | Derivative | Jan 15, 2026 | Grant/Award | 25,800 | $0.00 | $0.00 | 79,138 | Direct | โ | View Details | |
EVP, Corp and Development Ops | Restricted Stock Unit | Derivative | Jan 15, 2026 | Exercise/Conversion | 20,089 | $0.00 | $0.00 | 41,126 | Direct | โ | View Details | |
EVP, Corp and Development Ops | Restricted Stock Unit | Derivative | Jan 15, 2026 | Grant/Award | 9,675 | $0.00 | $0.00 | 50,801 | Direct | โ | View Details |